by Rachel Sauer, CU Anschutz Medical Campus Graphical abstract. Credit: Journal of Medicinal Chemistry (2022). DOI: 10.1021/acs.jmedchem.1c01778 An enzyme that has been identified as instrumental in the progression of many types of cancer is meeting its match in inhibitors synthesized and evaluated by University of Colorado (CU) Cancer Center researchers. In findings recently published in the Journal of...
